Proprietary Tool Identifies Best Recovery Setting for Patients Post Discharge, Sheds Light on Power of Episodes in Transforming Healthcare
New York, NY (June 17, 2019) — Remedy, America’s leading episodes of care company, today announced findings from its study, “Association of Decision Support for Hospital Discharge Disposition with Outcomes,” published in the June 2019 edition of The American Journal of Managed Care®. Remedy connects employers, insurance companies and health care systems to deliver more cost-effective care and improved consumer experiences.
The study verified the efficacy of a clinical decision support (CDS) algorithm in determining the optimal next site of care for patients leaving the hospital while avoiding unintended effects such as increases in readmissions, emergency department (ED) use and overall spending. The algorithm was built and tested within Remedy’s innovation incubator, Remedy Labs, and is currently in use by several Remedy partners through the proprietary Care at the Right Location (CARL) tool.
“Spending on post-acute care accounts for a substantial portion of overall healthcare costs and is growing faster than any other spending category, so it’s important for providers to be thoughtful about how they utilize those resources,” said study author and Chief Medical Officer at Remedy, Win Whitcomb, M.D. “The CARL tool is a gamechanger for organizations participating in value-based payment models like ACOs and bundled payments where this category represents an opportunity for savings, but it’s also important to patients who want to recover in the comfort of their own homes whenever possible.”
Takeaway points from the study include:
“At Remedy, we are constantly seeking new ways to drive greater value, efficiency, and health outcomes, and we’ve created something remarkable with CARL,” said Remedy President and CFO, Steve Senneff. “Many of our provider partners are already seeing the benefits of deploying the right resources at the right time, including better outcomes for patients and significant savings that can be reallocated to fulfill other needs. That is the promise of high-quality healthcare and the power of reorganizing care around patient episodes.”
This study entailed a retrospective review of a fee-for-service Medicare patients age 65 and older linked to a database of patients receiving CDS.
The study evaluated patients whose discharge disposition was consistent with the CDS recommendation versus those whose were not and patients receiving CDS for discharge disposition versus those who did not, regardless of concordance. Outcomes were linked to spending over a 90-day episode, 90-day readmissions and ED utilization not associated with a readmission.
Remedy Labs is an innovation incubator that identifies and studies the clinical efficiencies that are employed across Remedy’s business lines. Led by our clinicians, Remedy Labs analyzes our massive claims database to identify the levers that truly impact care delivery and promotes care redesign through shared knowledge to drive innovation in healthcare delivery via episodes. A central focus of Remedy Labs is the human aspect of care delivery, focusing on patient and value first, to highlight impact for patients and providers.
Remedy is America's leading episodes of care company, which connects employers, insurance companies, and health care systems to deliver more cost-effective care and improved consumer experiences. Remedy delivers software and services enabling health care providers and health insurers to organize and finance health care around patient episodes of care. The Company’s bundled payment network serves Medicare and private insurers and manages over $9 billion of annual health spending. For more information, visit www.powerofremedy.com.